These observations also are consistent with our findings that, unlike what is seen in some sporadic vascular tumors in humans, mutations of VHL are absent or infrequent in hemangiosarcoma, suggesting this disease entity may represent a distinct or specialized subset of blood vessel forming cells. This evidence concerns the gene VHL and angiosarcoma.